Viewing Study NCT00949819



Ignite Creation Date: 2024-05-05 @ 9:42 PM
Last Modification Date: 2024-10-26 @ 10:08 AM
Study NCT ID: NCT00949819
Status: RECRUITING
Last Update Posted: 2024-05-08
First Post: 2009-07-29

Brief Title: Active Surveillance for Cancer of the Prostate ASCaP
Sponsor: Jonsson Comprehensive Cancer Center
Organization: Jonsson Comprehensive Cancer Center

Study Overview

Official Title: The UCLA ASCAP Project is an Observational Longitudinal and Open-ended Study Aimed at Establishing a Structured Program of Non-interventional Follow-up for Localized Prostate Cancer
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ASCaP
Brief Summary: Active Surveillance AS of prostate cancer CaP is the systematic monitoring of men with low-risk localized lesions with curative treatment of those whose tumors show substantial progression AS is different from Watchful Waiting WW which is the palliative treatment of men with progressive prostate cancer
Detailed Description: This protocol is not designed as a formal clinical trial but rather an observational protocol no treatments and no randomization are included Longitudinally specimens and clinical data will be collected to provide information on the following

Imaging studies of the prostate
Rates of curative intervention
Measures of tumor recurrenceprogression
Disease specific survival
Overall survival
Clinical data to track Quality of Life

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None